Locanabio, Inc.
Creating RNA-targeting gene therapies to treat devastating diseases
7 employees · est. 2016 · San Diego, United States
SparingVision is the larger of the two.
Side-by-Side Comparison
| Metric | Locanabio, Inc. | SparingVision |
|---|---|---|
| Founded | ||
| Founded | 2016 | 2016 |
| Headquarters | ||
| Headquarters | San Diego, United States | Paris, France |
| Employees | ||
| Employees | 7 | 49 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Life Sciences |
| Funding Stage | ||
| Funding Stage | Series B | Series B |
| Total Funding | ||
| Total Funding | $155.55M | $119.50M |
| Funding Rounds | ||
| Funding Rounds | 3 | 3 |
| Services | ||
| Services | Not tracked yet | Development and delivery of innovative genomic medicines for ocular diseases |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients affected by inherited retinal diseases and ocular disorders |
| Taxonomy | ||
| Taxonomy | RNA-targeting Gene Therapy, Genetic Medicine, Neurodegenerative Diseases, Neuromuscular Diseases, Rare Genetic Diseases, RNA Biology, Gene Editing, Genomic Medicine, RNA-mediated Disease, Drug Development, Neurological Disorders | Genomic Medicines, Ocular Diseases, Inherited Retinal Diseases, Gene-independent Treatments, Research And Development, Retinitis Pigmentosa, Vision-Saving Treatments, Investment, Therapeutic Innovation, Pipeline Development, Rare Disease Treatment, International Collaboration, Sight-saving Treatments, Venture Capital |
| Website | ||
| Website | locanabio.com | sparingvision.com |
About Locanabio, Inc.
Locanabio, Inc., founded in 2016, is at the forefront of developing RNA-targeting gene therapies to address significant unmet medical needs. Their innovative approach focuses on correcting disease-causing RNA, utilizing a proprietary platform that includes advanced systems like snRNA, Cas13d, and PU...
About SparingVision
SparingVision is a biotechnology startup dedicated to developing genomic medicines for ocular diseases. Founded in 2016, the company aims to revolutionize the treatment of ocular diseases by translating over 20 years of world-leading ophthalmic research into vision-saving therapies. The core focus o...
We will tell you when either one moves
BounceWatch watches Locanabio, Inc. and SparingVision for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Locanabio, Inc. and SparingVision — by email.
Frequently Asked Questions
Compare Locanabio, Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Locanabio, Inc. on 11 Sep 2024, and SparingVision on 7 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.